"At AOP Health, we strive to develop and market innovative and effective therapies for patients with rare diseases and in critical care. This is our daily motivation to provide sustainable support to those who need it most - the patients!"
Personal Data Sheet
Dr. Martin Steinhart graduated in medicine from the University of Vienna. He gained solid national and international experience in various pharmaceutical companies in the areas of Medical Affairs, Clinical and Regulatory Operations as well as Safety & Quality in Austria and CEE. He joined AOP Health in July 2019 as a Chief of Research & Development being accountable for the organizational, structural, and strategic set-up of the R&D area. Martin is Co-CEO of AOP Orphan Pharmaceutical GmbH and responsible for Research & Development, Medical Affairs, Business Development, Technical Operations and the Program Management Office.